Subscribe to Search results

Considering the evidence, there was always likely to be sufficient cryoprecipitate capable of being produced. However, clinicians, and no doubt many patients too, wished for the added advantages which factor concentrates offered, particularly in terms of home therapy.

Published on:

A patient at Birmingham Childrens' Hospital had been unaware that he had been HIV positive until he was transferred to Stoke-on-Trent Haemophilia Centre, where his new clinician said, "Hello, I see you're HIV positive."

Published on:

Graham Manning's treatment with US Factor 9 concentrate was not recorded in his notes; only his subsequent treatment with cryoprecipitate and NHS Factor 8 was recorded.

Published on:

In oral evidence Mr John Cornes described a lack of communication in respect of risks of infection and advice on the subject.

Published on:

Terry McStay was 34 when he died of AIDS on 3 November 1984, having first become ill in 1983.

Published on:

Gill Fyffe was unwell for seven years after her transfusion before she was identified as having been infected with Hepatitis C in the lookback in 1995.

Published on:

John McDougall noted in oral evidence that Dr Willoughby, from the Royal Hospital for Sick Children in Glasgow, had not discussed the risk of AIDS with parents and come to a consensus.

Published on:

In oral evidence John McDougall stated that as parent he had never been informed of the risks while his son was treated at RHSC

Published on:

In oral evidence Alice Mackie noted that the wife of a patient had recalled how her husband was always told there was nothing to worry about and that all blood donors had not had AIDS and that it had been safe

Published on:

In oral evidence Alice Mackie stated that the wife of a patient had recalled how they had believed that her husband had not been infected following a large group meeting as they had felt that had he been infected that they would have been told.

Published on:

There is evidence that blood was also taken from family members and used for research purposes, the nature of which remains unclear, with no explanation being given as to the purpose of the blood testing: see the evidence of Alice Mackie.

Published on:

Richard Warwick, a student at Treloar's, stated that "they were crazy about prophylactics at Treloars' and prophylaxis was used 'like every day'.

Published on:

The parents of a one-year old previously untreated boy with Haemophilia A, was treated with concentrate in July 1983 at the paediatric ward at the University Hospital of Wales, were not told by any of the treating clinicians that there was a risk of NANBH, even though Professor Bloom informed the GP a few days later that "all these materials carry the risk of hepatitis, particularly non-A non-B, but this is something haemophiliacs have to accept".

Published on:

Various witnesses, both anonymous and otherwise, gave evidence to the Inquiry and were questioned by Counsel to the Inquiry about their experience of infection - both personal, and infections of their loved ones.

Published on:

Christopher Bishop described Professor Bloom as an influential figure and said he was later described by the pharmaceutical company's UK marketing manager as an "opinion former".

Published on:

Christopher Bishop stated in his oral evidence that Armour had no qualms internally about disposing of or selling pre-March 1983 product in the UK.

Published on:

Christopher Bishop told the Inquiry that product literature was produced by Armour on the expectation that it would be read and considered by doctors rather than patients.

Published on:

In the absence of firm evidence of a product being implicated in the transmission of AIDS, Mr Bishop stated they he was not concerned about the absence of a product warning.

Published on:

Christopher Bishop asserted in his oral evidence that Armour had done: "everything possible to provide the best possible treatment and the most up-to-date systems in accordance with the state of art at that time."

Published on:

The Trent RTC acted as a reference laboratory for hospital blood banks in the area and provided regional services for antenatal blood groups, serology and for histocompatibility.

Published on: